Skip to main content

Table 3 Weight, length, and head circumference growth rates from 14 days to 30, 60, 90, and 120 days of age

From: Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial

Gender Day Group (n) Growth rate*
Weight† (g/day) Length (cm/day) Head circumference (cm/day)
male 30 Control (74) 48.9 ± 1.5 0.15 ± 0.009 0.10 ± 0.005
   PDX/GOS (68) 45.2 ± 1.5‡ 0.15 ± 0.009 0.10 ± 0.005
   GOS (68) 46.7 ± 1.6 0.13 ± 0.009 0.10 ± 0.005
  60 Control (66) 41.3 ± 1.1 0.13 ± 0.004 0.08 ± 0.002
   PDX/GOS (59) 41.4 ± 1.2 0.13 ± 0.004 0.07 ± 0.002
   GOS (60) 41.9 ± 1.2 0.13 ± 0.004 0.07 ± 0.002
  90 Control (62) 36.1 ± 1.0 0.12 ± 0.003 0.07 ± 0.002
   PDX/GOS (55) 37.4 ± 1.0 0.12 ± 0.003 0.06 ± 0.002
   GOS (52) 36.8 ± 1.1 0.12 ± 0.003 0.06 ± 0.002
  120 Control (63) 32.6 ± 0.8 0.11 ± 0.002 0.06 ± 0.001
   PDX/GOS (54) 34.0 ± 0.9 0.11 ± 0.002 0.06 ± 0.001
   GOS (50) 33.3 ± 0.9 0.11 ± 0.002 0.06 ± 0.001
female 30 Control (52) 38.4 ± 1.5 0.15 ± 0.012 0.09 ± 0.006
   PDX/GOS (50) 34.9 ± 1.6 0.12 ± 0.012 0.08 ± 0.007
   GOS (49) 34.6 ± 1.6‡ 0.11 ± 0.012 0.09 ± 0.007
  60 Control (43) 32.4 ± 1.2 0.12 ± 0.005 0.07 ± 0.003
   PDX/GOS (44) 32.1 ± 1.2 0.12 ± 0.005 0.06 ± 0.003
   GOS (42) 32.2 ± 1.3 0.12 ± 0.006 0.07 ± 0.003
  90 Control (40) 29.0 ± 1.0 0.11 ± 0.003 0.06 ± 0.002
   PDX/GOS (43) 29.7 ± 0.9 0.11 ± 0.003 0.05 ± 0.002
   GOS (38) 29.3 ± 1.0 0.11 ± 0.003 0.06 ± 0.002
  120 Control (38) 27.6 ± 0.9 0.10 ± 0.003 0.05 ± 0.002
   PDX/GOS (44) 27.9 ± 0.8 0.10 ± 0.002 0.05 ± 0.001
   GOS (39) 27.3 ± 0.9 0.10 ± 0.003 0.05 ± 0.002
  1. * Mean ± standard error (SE).
  2. † Adjusted for body weight at enrollment.
  3. ‡ Significantly lower than Control, P < 0.05, one-tailed test.